OTC •
Healthcare •
Medical Devices •
Quote as of 06/18/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeOTC
Market Capitalization29.17 mln
Float26.69 mln
Earnings Date06/30/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
5.62
Highly suspicious
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
0.02
Debt-free
ROE
-335
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
PetVivo Holdings Inc. is a Minnesota-based company focused on developing and selling medical treatments for animals. Its main product, Spryng, is an injection given by veterinarians directly into the joints of dogs and horses to relieve pain and improve movement caused by conditions like osteoarthritis. The company also works on treatment solutions intended for broader use in both animal and human healthcare.